<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03047655</url>
  </required_header>
  <id_info>
    <org_study_id>GesundLeben</org_study_id>
    <nct_id>NCT03047655</nct_id>
  </id_info>
  <brief_title>Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome</brief_title>
  <acronym>GesundLeben</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A growing number of cross-sectional studies is investigated the role of the human lipidome as&#xD;
      a new biomarker for metabolic diseases. However, data on this issue is still sparse and&#xD;
      especially interventional data is not available up to now.&#xD;
&#xD;
      &quot;GesundLeben&quot; will provide data on 100 human subjects with metabolic syndrome, undergoing&#xD;
      distinct types of lifestyle intervention for 6 weeks. Standardized metabolic assessment will&#xD;
      be covered with routine laboratory parameters and oral glucose tolerance test as well as&#xD;
      non-radiologic anthropometric measurements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A growing number of cross-sectional studies is investigated the role of the human lipidome as&#xD;
      a new biomarker for metabolic diseases. However, data on this issue is still sparse and&#xD;
      especially interventional data is not available up to now. We intend to clarify, if the human&#xD;
      lipidome is correlating with metabolic state and if changes in this state reflect on the&#xD;
      lipidome. Using high-throughput shot-gun technique, we will be able to measure several&#xD;
      hundreds of lipid species in one blood sample.&#xD;
&#xD;
      The &quot;GesundLeben&quot; trial will provide data on 100 human subjects with metabolic syndrome,&#xD;
      undergoing distinct types of lifestyle intervention for 6 weeks. The cohort will be designed&#xD;
      to include participants from both sexes, but be restricted on subjects without impaired&#xD;
      glucose tolerance.&#xD;
&#xD;
      Standardized metabolic assessment will be covered with routine laboratory parameters (e.g.&#xD;
      transaminases, HbA1c) and oral glucose tolerance test as well as non-radiologic&#xD;
      anthropometric measurements (BMI, WHR, BIA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in lipidome pattern</measure>
    <time_frame>6 weeks</time_frame>
    <description>complex human lipidome (blood levels of several hundreds of lipid species) will be assessed before and after intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>reduction of blood pressure</measure>
    <time_frame>6 weeks</time_frame>
    <description>systolic and diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NAFLD reduction</measure>
    <time_frame>6 weeks</time_frame>
    <description>NAFLD, estimated by fatty liver index (FLI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>weight loss</measure>
    <time_frame>6 weeks</time_frame>
    <description>loss in body weight / BMI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of insulin resistance</measure>
    <time_frame>6 weeks</time_frame>
    <description>assessed by oral glucose tolerance test, glucose and insulin levels; IS indices (Matsuda, IGI etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>standardized questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>NAFLD</condition>
  <condition>Obesity</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Physical activity only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal&#xD;
additionally, subjects will be provided with one healthy muffin per day (450 kcal; low GI, high load of PUFA and isomaltulose) over 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle intervention (physical activity)</intervention_name>
    <description>Dietary treatment with or without additional motivation on more physical activity</description>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
    <arm_group_label>Physical activity only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lifestyle intervention (PUFA/isomaltulose-enriched muffin)</intervention_name>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hypertension&#xD;
&#xD;
          -  NAFLD&#xD;
&#xD;
          -  obesity&#xD;
&#xD;
          -  hyperuricemia&#xD;
&#xD;
          -  dyslipoproteinemia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  prediabetes / overt diabetes mellitus&#xD;
&#xD;
          -  present cancer&#xD;
&#xD;
          -  systemic infection&#xD;
&#xD;
          -  chronic inflammatory disease&#xD;
&#xD;
          -  recent stroke / myocardial infarction (6 months)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  addiction / severe psychiatric diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Kabisch, Dr.med.</last_name>
    <phone>030 450 514 429</phone>
    <email>stefan.kabisch@dife.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Bergholz-Rehbr√ºcke</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <contact_backup>
      <last_name>Silke Hornemann</last_name>
      <phone>033200 88 2779</phone>
      <email>silke.hornemann@dife.de</email>
    </contact_backup>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Hornemann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiana Gerbracht, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DIfE (German Institute for Human Nutrition)</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <phone>030 450 514 429</phone>
      <email>stefan.kabisch@dife.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 21, 2016</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Director (Dpt. Clinical Nutrition)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

